May 13, 2026
Chondroitin Sulfate Sourcing in 2026: What 240 Million Osteoarthritis Patients Mean For Supply
Osteoarthritis affects over 240 million people worldwide. And the number of people over 60 is set to double by 2050. Here's what that means for the chondroit...
-
![Breakthrough in The Billion Dollar Inhalation Preparation Market]()
Apr 22, 2024Breakthrough in The Billion Dollar Inhalation Preparation MarketAs a first-line therapy for chronic obstructive pulmonary disease and asthma, the global inhalation market is showing a thriving trend. From the pe...view more -
![Vantage Expands Taurate Capacity in Germany]()
Apr 16, 2024Vantage Expands Taurate Capacity in GermanyVantage Specialty Chemicals, Inc. said it is expanding taurate capacity at its major manufacturing site in Leuna, Germany. The company said the mul...view more -
![Will The Diagnostic Criteria For Diabetes Be Changed?]()
Apr 15, 2024Will The Diagnostic Criteria For Diabetes Be Changed?Recently, the International diabetes Federation (IDF) released the IDF's Position Statement on Hyperglycemia and Type 2 diabetes in the Diagnos...view more -
![Long Term Use Of Progesterone Increases The Risk Of Intracranial Meningioma]()
Apr 11, 2024Long Term Use Of Progesterone Increases The Risk Of Intracranial MeningiomaRecently, BMJ published a study titled "Use of progressions and the risk of intracranial meningioma: national case control study", which ...view more -
![Latest: β- Receptor Blockers May Not Effectively Reduce The Risk Of Acute Myo...]()
Apr 10, 2024Latest: β- Receptor Blockers May Not Effectively Reduce The Risk Of Acute Myo...On April 7, 2024, NEJM published a paper titled Beta Blockers after Myocardial Infarction and Preserved Ejection Fraction, using β- The clinic...view more -
![$5 Billion Vitiligo Market Breaks New Ground]()
Apr 08, 2024$5 Billion Vitiligo Market Breaks New GroundOn April 1st, Kangzhe Pharmaceutical announced a partnership with Incyte regarding the selective oral administration of the JAK1 inhibitor Povorcit...view more -
![Five People Have Died After Taking Kobayashi Pharmaceutical Health Supplement...]()
Mar 29, 2024Five People Have Died After Taking Kobayashi Pharmaceutical Health Supplement...(CNN) March 29, according to the Japan Broadcasting Corporation (NHK) reported that on the 29th, Japan's Kobayashi Pharmaceutical Company issue...view more -
![Data From Clinical Study Of Super 3CL Inhibitor Tazovid To Be Published in Th...]()
Mar 27, 2024Data From Clinical Study Of Super 3CL Inhibitor Tazovid To Be Published in Th...Cosunter's first-in-class innovative drug Tazovid, Super 3CL inhibitor's registration clinical study data will be published in the authoritative in...view more -
![Kangpu's CRBN-E3 Ligase Modulator Receives Clinical Approval in China]()
Mar 26, 2024Kangpu's CRBN-E3 Ligase Modulator Receives Clinical Approval in ChinaIndication is systemic lupus erythematosusview more -
![Teruisi CD20 ADC To Be Included in Breakthrough Therapeutic Varieties]()
Mar 08, 2024Teruisi CD20 ADC To Be Included in Breakthrough Therapeutic VarietiesThe indication is relapsed or refractory CD20-positive diffuse large B-cell lymphoma after at least 2 standard treatments.view more -
![Just Now! The First-ever NASH Drug Approved, Exclusively Capturing A Billion-...]()
Mar 15, 2024Just Now! The First-ever NASH Drug Approved, Exclusively Capturing A Billion-...In the early hours of March 15, 2024, the United States Food and Drug Administration (FDA) has expedited the approval of Rezdiffra (Resmetirom) to ...view more -
![CARsgen's BCMA CAR-T Approved For Marketing, Exclusive Commercialisation Righ...]()
Mar 06, 2024CARsgen's BCMA CAR-T Approved For Marketing, Exclusive Commercialisation Righ...On 1 March, CARsgen announced that Zevorcabtagene Autoleucel Injection was approved for marketing by the National Medical Products Administration (...view more
